Axsome Therapeutics (AXSM) EBITDA (2015 - 2026)
Axsome Therapeutics (AXSM) posted EBITDA of -$8.01 million for Q3 2026, compared with -$43.7 million a year earlier.
Powered by 
Analysis
Axsome Therapeutics (AXSM) EBITDA (2015 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, EBITDA at Axsome Therapeutics was -$140.44 million; for FY2025, it came in at -$157.7 million.
- In prior years, Axsome Therapeutics' EBITDA was -$271 million in FY2024, -$222.42 million in FY2023, -$173.91 million in FY2022 and -$123.55 million in FY2021.
- The Q3 2026 figure stands as the highest quarterly EBITDA since Q1 2023.
- According to Business Quant data, EBITDA for the three prior quarters was -$46.76 million (Q2 2026), -$60.99 million (Q1 2026) and -$24.68 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 13.33 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 7.37 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Axsome Therapeutics | 7.37 Bn | 6.11 Bn | 241.89 Mn | -8.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -8.01 Mn |
| Jun 30, 2026 | -46.76 Mn |
| Mar 31, 2026 | -60.99 Mn |
| Dec 31, 2025 | -24.68 Mn |
| Sep 30, 2025 | -43.70 Mn |
| Jun 30, 2025 | -34.47 Mn |
| Mar 31, 2025 | -54.59 Mn |
| Dec 31, 2024 | -70.17 Mn |
| Sep 30, 2024 | -60.56 Mn |
| Jun 30, 2024 | -76.05 Mn |
| Mar 31, 2024 | -64.94 Mn |
| Dec 31, 2023 | -96.08 Mn |
| Sep 30, 2023 | -59.75 Mn |
| Jun 30, 2023 | -62.46 Mn |
| Mar 31, 2023 | -4.10 Mn |
| Dec 31, 2022 | -57.88 Mn |
| Sep 30, 2022 | -40.28 Mn |
| Jun 30, 2022 | -37.73 Mn |
| Mar 31, 2022 | -38.03 Mn |
| Dec 31, 2021 | -32.35 Mn |
API Access
Axsome Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=AXSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "AXSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=AXSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();